Penicillin remains the most useful antibiotic for treatment of infections due to organisms sensitive to this drug because of its bacteriocidal properties and its freedom from toxicity. Enormous doses may broaden its antibacterial spectrum and it may act synergistically with certain other drugs. New penicillin compounds have been developed which serve such special purposes as (1) concentration in lung tissue, (2) maintenance of therapeutic concentrations in the blood for long periods after injection, (3) avoidance of allergic reactions and (4) prolongation of therapeutic content in the blood after oral administration. Erythromycin and carbomycin may be effective against bacterial infections not sensitive to other antibacterial drugs. Streptomycin combined with dihydrostreptomycin is less toxic than is either drug used alone. Isoniazid is a valuable antituberculosis drug, especially when combined with streptomycin.Viomycin may be useful in treating tuberculous infections that have become resistant to other specific drugs.

Anti-Bacterial Agents↗

PubMed1953

[Present trends in antibacterial pharmacotherapy of tuberculosis].

Explore the source record for details and available documents.

Anti-Bacterial Agents↗

PubMed1953

Reduced ototoxicity by combined streptomycin-dihydrostreptomycin treatment of tuberculosis; follow-up report.

Explore the source record for details and available documents.

Combined Modality Therapy↗

PubMed1953

[Present orientation in drug therapy of tuberculosis].

Explore the source record for details and available documents.

Aminosalicylic Acid↗

PubMed1952

Therapy of pulmonary tuberculosis with isoniazid alone and in combination with streptomycin and with para-amino-salicylic acid.

Explore the source record for details and available documents.

Amino Acids↗